Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06854185 · ClinicalTrials.gov registry record · NA

Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease

A NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease, sponsored by Baylor College of Medicine.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06854185 is a NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 50 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06854185, a NA study of Metabolic Syndrome and Metabolic Dysfunction Associated Steatotic Liver Disease, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn whether the Paso weight loss program is feasible for Mexican and Central American patients with fatty liver disease. In addition, the investigators will also look at whether the program improves weight loss, fatty liver disease, physical activity, diet, and family support among patients.

Interventions

  • BEHAVIORAL Paso Program

Study Locations (1)

Texas

  • Harris Health - Smith - Houston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-02-05
Est. Completion 2026-12-31
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT06854185

The ClinicalTrials.gov registry entry for NCT06854185 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Paso Program is the first listed.

NCT06854185 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06854185 about?

NCT06854185 is a clinical study titled "Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease". The purpose of this study is to learn whether the Paso weight loss program is feasible for Mexican and Central American patients with fatty liver disease. In addition, the investigators will also look at whether the program improves weight loss, fatty liver disease, physical activity, diet, and fami...

What is the current status of trial NCT06854185?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-02-05. Estimated completion is 2026-12-31.

What conditions does trial NCT06854185 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Metabolic Dysfunction Associated Steatotic Liver Disease, Overweight (BMI > 25).

What interventions are being tested in trial NCT06854185?

The interventions under investigation include: Paso Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06854185?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06854185 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.